Loss of TET2 with reduced genomic 5-hmC is associated with adverse-risk AML

被引:5
作者
Pethusamy, Karthikeyan [1 ]
Seethy, Ashikh [1 ]
Dhar, Ruby [1 ]
Karmakar, Abhibroto [1 ]
Chaudhary, Shilpi [2 ]
Bakhshi, Sameer [2 ]
Kumar, Jayanth P. [1 ]
Chopra, Anita [2 ]
Chauhan, Shyam S. [1 ]
Karmakar, Subhradip [1 ]
机构
[1] All India Inst Med Sci, Dept Biochem, Room 3020, New Delhi 110029, India
[2] All India Inst Med Sci, Dr BR Ambedkar Inst Rotary Canc Hosp, New Delhi, India
关键词
Acute myeloid leukemia; TET2; DNMT; cancer epigenetics; DNA DEMETHYLATION; VITAMIN-C; 5-METHYLCYTOSINE; MUTATIONS; DNMT3A; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; DIFFERENTIATION; CONVERSION; PROGNOSIS;
D O I
10.1080/10428194.2022.2126278
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
While considerable information exists on the ten-eleven translocation 2 (TET2) mutational landscape in AML, the information on TET2 expression is limiting. So, we aimed to study the TET2 expression at mRNA and protein levels in AML patients compared to healthy controls. To achieve this, we recruited 70 non-M3, de novo AML patients and 20 healthy controls. The expression of TET2 was checked at mRNA and protein levels by qPCR and ELISA respectively and the TET activity was checked by the 5-hmC assay. TET2 mRNA expression was correlated with clinicopathological parameters and overall survival. We found a significant downregulation of TET2 mRNA and protein and significantly lower DNA 5-hmC levels in AML patients compared to controls. TET2 downregulation was more in patients with high blast counts and patients of the adverse-risk ELN category. We also found a significant upregulation of DNMT1 and DNMT3a suggesting a hypermethylation phenotype in de novo AML.
引用
收藏
页码:3426 / 3432
页数:7
相关论文
共 40 条
[1]   Prognostic significance of DNMT3a gene expression and reactive nitrogen species in newly diagnosed Egyptian de novo adult acute myeloid leukemia patients [J].
Asfour, Inas A. ;
Hegab, Hany M. ;
El-Salakawy, Walaa A. ;
Hamza, Mohamed T. ;
Mansour, Dina A. ;
Saeed, Alia M. .
EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2020, 21 (01)
[2]   Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells [J].
Blaschke, Kathryn ;
Ebata, Kevin T. ;
Karimi, Mohammad M. ;
Zepeda-Martinez, Jorge A. ;
Goyal, Preeti ;
Mahapatra, Sahasransu ;
Tam, Angela ;
Laird, Diana J. ;
Hirst, Martin ;
Rao, Anjana ;
Lorincz, Matthew C. ;
Ramalho-Santos, Miguel .
NATURE, 2013, 500 (7461) :222-+
[3]  
Bottomly D, 2022, CANCER CELL, V40, P850, DOI 10.1016/j.ccell.2022.07.002
[4]   TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics [J].
Chou, Wen-Chien ;
Chou, Sheng-Chieh ;
Liu, Chieh-Yu ;
Chen, Chien-Yuan ;
Hou, Hsin-An ;
Kuo, Yuan-Yeh ;
Lee, Ming-Cheng ;
Ko, Bor-Sheng ;
Tang, Jih-Luh ;
Yao, Ming ;
Tsay, Woei ;
Wu, Shang-Ju ;
Huang, Shang-Yi ;
Hsu, Szu-Chun ;
Chen, Yao-Chang ;
Chang, Yi-Chang ;
Kuo, Yi-Yi ;
Kuo, Kuan-Ting ;
Lee, Fen-Yu ;
Liu, Ming-Chi ;
Liu, Chia-Wen ;
Tseng, Mei-Hsuan ;
Huang, Chi-Fei ;
Tien, Hwei-Fang .
BLOOD, 2011, 118 (14) :3803-3810
[5]   Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate [J].
Das, Andrew B. ;
Smith-Diaz, Carlos C. ;
Vissers, Margreet C. M. .
HAEMATOLOGICA, 2021, 106 (01) :14-25
[6]   Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing [J].
Ding, Li ;
Ley, Timothy J. ;
Larson, David E. ;
Miller, Christopher A. ;
Koboldt, Daniel C. ;
Welch, John S. ;
Ritchey, Julie K. ;
Young, Margaret A. ;
Lamprecht, Tamara ;
McLellan, Michael D. ;
McMichael, Joshua F. ;
Wallis, John W. ;
Lu, Charles ;
Shen, Dong ;
Harris, Christopher C. ;
Dooling, David J. ;
Fulton, Robert S. ;
Fulton, Lucinda L. ;
Chen, Ken ;
Schmidt, Heather ;
Kalicki-Veizer, Joelle ;
Magrini, Vincent J. ;
Cook, Lisa ;
McGrath, Sean D. ;
Vickery, Tammi L. ;
Wendl, Michael C. ;
Heath, Sharon ;
Watson, Mark A. ;
Link, Daniel C. ;
Tomasson, Michael H. ;
Shannon, William D. ;
Payton, Jacqueline E. ;
Kulkarni, Shashikant ;
Westervelt, Peter ;
Walter, Matthew J. ;
Graubert, Timothy A. ;
Mardis, Elaine R. ;
Wilson, Richard K. ;
DiPersio, John F. .
NATURE, 2012, 481 (7382) :506-510
[7]   Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel [J].
Doehner, Hartmut ;
Estey, Elihu ;
Grimwade, David ;
Amadori, Sergio ;
Appelbaum, Frederick R. ;
Buechner, Thomas ;
Dombret, Herve ;
Ebert, Benjamin L. ;
Fenaux, Pierre ;
Larson, Richard A. ;
Levine, Ross L. ;
Lo-Coco, Francesco ;
Naoe, Tomoki ;
Niederwieser, Dietger ;
Ossenkoppele, Gert J. ;
Sanz, Miguel ;
Sierra, Jorge ;
Tallman, Martin S. ;
Tien, Hwei-Fang ;
Wei, Andrew H. ;
Lowenberg, Bob ;
Bloomfield, Clara D. .
BLOOD, 2017, 129 (04) :424-447
[8]   TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair [J].
Feng, Yimei ;
Li, Xiaoping ;
Cassady, Kaniel ;
Zou, Zhongmin ;
Zhang, Xi .
FRONTIERS IN ONCOLOGY, 2019, 9
[9]   Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG) [J].
Gaidzik, Verena I. ;
Schlenk, Richard F. ;
Paschka, Peter ;
Stoelzle, Anja ;
Spaeth, Daniela ;
Kuendgen, Andrea ;
von Lilienfeld-Toal, Marie ;
Brugger, Wolfram ;
Derigs, Hans Guenter ;
Kremers, Stephan ;
Greil, Richard ;
Raghavachar, Aruna ;
Ringhoffer, Mark ;
Salih, Helmut R. ;
Wattad, Mohammed ;
Kirchen, Heinz G. ;
Runde, Volker ;
Heil, Gerhard ;
Petzer, Andreas L. ;
Girschikofsky, Michael ;
Heuser, Michael ;
Kayser, Sabine ;
Goehring, Gudrun ;
Teleanu, Maria-Veronica ;
Schlegelberger, Brigitte ;
Ganser, Arnold ;
Krauter, Juergen ;
Bullinger, Lars ;
Doehner, Hartmut ;
Doehner, Konstanze .
BLOOD, 2013, 121 (23) :4769-4777
[10]   Epigenetic Modifications in Acute Myeloid Leukemia: Prognosis, Treatment, and Heterogeneity [J].
Goldman, Samantha L. ;
Hassan, Ciaran ;
Khunte, Mihir ;
Soldatenko, Arielle ;
Jong, Yunji ;
Afshinnekoo, Ebrahim ;
Mason, Christopher E. .
FRONTIERS IN GENETICS, 2019, 10